Adamis Pharmaceuticals reported $1.55M in Trade Debtors for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Trade Debtors Change
Adamis Pharmaceuticals ADMP:US USD 1.55M 597.95K
Adma Biologics ADMA:US USD 20.9M 2.02M
Brainstorm Cell Therapeutics BCLI:US USD 58K 59K
Cara Therapeutics CARA:US USD 10.77M 1.6M
Glaxosmithkline GSK:US GBP 7.46B 636M
GlaxoSmithKline GSK:LN GBP 7.46B 636M